Enhancing clinical islet transplantation through tissue engineeering strategies

Jaime A. Giraldo, Jessica D. Weaver, Cherie L. Stabler

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Clinical islet transplantation (CIT), the infusion of allogeneic islets within the liver, has the potential to provide precise and sustainable control of blood glucose levels for the treatment of type 1 diabetes. The success and long?term outcomes of CIT, however, are limited by obstacles such as a nonoptimal transplantation site and severe inflammatory and immunological responses to the transplant. Tissue engineering strategies are poised to combat these challenges. In this review, emerging methods for engineering an optimal islet transplantation site, as well as novel approaches for improving islet cell encapsulation, are discussed.

Original languageEnglish (US)
Pages (from-to)1238-1247
Number of pages10
JournalJournal of Diabetes Science and Technology
Volume4
Issue number5
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Islets of Langerhans Transplantation
Transplants
Medical problems
Encapsulation
Tissue engineering
Liver
Glucose
Blood Glucose
Blood
Tissue
Tissue Engineering
Type 1 Diabetes Mellitus
Islets of Langerhans
Transplantation
Therapeutics

Keywords

  • Bioartificial pancreas
  • Biomaterials
  • Devices
  • Encapsulation
  • Islet transplantation
  • Scaffold

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering

Cite this

Enhancing clinical islet transplantation through tissue engineeering strategies. / Giraldo, Jaime A.; Weaver, Jessica D.; Stabler, Cherie L.

In: Journal of Diabetes Science and Technology, Vol. 4, No. 5, 09.2010, p. 1238-1247.

Research output: Contribution to journalReview article

@article{85e84477626545ab80614b7aa821fdb0,
title = "Enhancing clinical islet transplantation through tissue engineeering strategies",
abstract = "Clinical islet transplantation (CIT), the infusion of allogeneic islets within the liver, has the potential to provide precise and sustainable control of blood glucose levels for the treatment of type 1 diabetes. The success and long?term outcomes of CIT, however, are limited by obstacles such as a nonoptimal transplantation site and severe inflammatory and immunological responses to the transplant. Tissue engineering strategies are poised to combat these challenges. In this review, emerging methods for engineering an optimal islet transplantation site, as well as novel approaches for improving islet cell encapsulation, are discussed.",
keywords = "Bioartificial pancreas, Biomaterials, Devices, Encapsulation, Islet transplantation, Scaffold",
author = "Giraldo, {Jaime A.} and Weaver, {Jessica D.} and Stabler, {Cherie L.}",
year = "2010",
month = "9",
doi = "10.1177/193229681000400525",
language = "English (US)",
volume = "4",
pages = "1238--1247",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "5",

}

TY - JOUR

T1 - Enhancing clinical islet transplantation through tissue engineeering strategies

AU - Giraldo, Jaime A.

AU - Weaver, Jessica D.

AU - Stabler, Cherie L.

PY - 2010/9

Y1 - 2010/9

N2 - Clinical islet transplantation (CIT), the infusion of allogeneic islets within the liver, has the potential to provide precise and sustainable control of blood glucose levels for the treatment of type 1 diabetes. The success and long?term outcomes of CIT, however, are limited by obstacles such as a nonoptimal transplantation site and severe inflammatory and immunological responses to the transplant. Tissue engineering strategies are poised to combat these challenges. In this review, emerging methods for engineering an optimal islet transplantation site, as well as novel approaches for improving islet cell encapsulation, are discussed.

AB - Clinical islet transplantation (CIT), the infusion of allogeneic islets within the liver, has the potential to provide precise and sustainable control of blood glucose levels for the treatment of type 1 diabetes. The success and long?term outcomes of CIT, however, are limited by obstacles such as a nonoptimal transplantation site and severe inflammatory and immunological responses to the transplant. Tissue engineering strategies are poised to combat these challenges. In this review, emerging methods for engineering an optimal islet transplantation site, as well as novel approaches for improving islet cell encapsulation, are discussed.

KW - Bioartificial pancreas

KW - Biomaterials

KW - Devices

KW - Encapsulation

KW - Islet transplantation

KW - Scaffold

UR - http://www.scopus.com/inward/record.url?scp=78751513664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751513664&partnerID=8YFLogxK

U2 - 10.1177/193229681000400525

DO - 10.1177/193229681000400525

M3 - Review article

C2 - 20920446

AN - SCOPUS:78751513664

VL - 4

SP - 1238

EP - 1247

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 5

ER -